Efficacy and Safety Evaluation of Neobianacid® in GERD and EPS

NCT03238534 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

275

Enrollment

INDUSTRY

Sponsor class

Conditions

GERD
EPS

Interventions

DEVICE: Neobianacid®
DRUG: Omeprazole 20mg
OTHER: Neobianacid® placebo
OTHER: Omeprazole placebo

Sponsor

Aboca Spa Societa' Agricola

Collaborators

[object Object]
[object Object]
[object Object]